Among these, preclinical studies have identified the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade as one of the key regulatory axes implicated in iCCA aggressiveness, chemoresistance, and immune modulation [14,19,20,21]. Here, MAPK3 is linked to infantile convulsions and choreoathetosis.